Answers are grounded in this paper and cite their sources.
Many NF1 PN were associated with clinically significant morbidity at baseline, highlighting the need for longitudinal morbidity evaluations starting at an early age to capture changes in PN-associated morbidities. Prospective evaluation of standardized patient reported and functional outcomes in clinical trials are ongoing and may allow further characterization of the association of PN volume increase or decrease and clinical changes.
No takes yet. Share an insight, caveat, or question.
Gross et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: